Amphastar Pharmaceuticals (AMPH) PT Lowered to $20 at Jefferies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amphastar Pharmaceuticals (AMPH) PT Lowered to $20 at Jefferies

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2017

May 8, 2017 4:05 PM EDT

RANCHO CUCAMONGA, Calif., May 08, 2017 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the three months ended March 31, 2017.

First Quarter Highlights

Net revenues of $56.7 million for the first quarterGAAP net income of $0.9 million, or $0.02 per diluted share, for the first quarterAdjusted non-GAAP net income of $4.5 million, or $0.09 per diluted share, for the first quarter

Dr. Jack Zhang, Amphastars CEO, commented:  We continue to execute on our... More